TickerFacts.

Company research / COR

Cencora, Inc. (COR)

Build a valuation ↗↓ Download CSV

CIK 0001140859 · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

  • Sector Wholesale Trade
  • Incorporated DE
  • Fiscal year ends Sep 30

For the year ended 2025-09-30, Cencora, Inc. reported revenue of $321.33B. Revenue grew 9.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $332.77B.

Key ratios (year ended 2025-09-30)

3.6%
Gross margin
0.8%
Operating margin
0.5%
Net margin
103.1%
Return on year-end equity
9.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Headquarters locality: Chesterbrook · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-30
Revenue$332.77B$321.33B$293.96B$262.17B$238.59B$213.99B$189.89B$179.59B$167.94B$153.14B$146.85B
Cost of Revenue$319.55B$309.85B$284.05B$253.21B$230.29B$207.05B$184.70B$174.45B$163.33B$148.60B$142.58B
Gross Profit$13.22B$11.48B$9.91B$8.96B$8.30B$6.94B$5.19B$5.14B$4.61B$4.55B$4.27B
Operating Income$3.04B$2.63B$2.18B$2.34B$2.37B$2.35B-$5.14B$1.11B$1.44B$1.06B$1.53B
Depreciation & Amortization$1.04B$1.05B$1.09B$963.90M$693.89M$505.17M$391.06M$462.41M$465.13M$397.60M$364.74M
EBITDA$4.08B$3.68B$3.27B$3.30B$3.06B$2.86B-$4.74B$1.57B$1.91B$1.46B$1.89B
Net Income$2.62B$1.55B$1.51B$1.75B$1.70B$1.54B-$3.41B$855.37M$1.66B$364.48M$1.43B
EPS (Diluted)n/a$7.96$7.53$8.53$8.04$7.39-$16.65$4.04$7.53$1.64$6.32
Total Assets$83.81B$76.59B$67.10B$62.56B$56.56B$57.34B$44.27B$39.17B$37.67B$35.32B$33.64B
Long-Term Debt$11.72B$7.66B$4.39B$4.79B$5.70B$6.68B$4.12Bn/an/a$3.44B$4.19B
Shareholders' Equity$3.05B$1.51B$645.94M$522.00M-$211.56M$223.35M-$1.02B$2.88B$2.93B$2.06B$2.13B
Cash & Equivalents$2.82B$4.36B$3.13B$2.59B$3.39B$2.55B$4.60B$3.37B$2.49B$2.44B$2.74B
Operating Cash Flow$4.82B$3.88B$3.48B$3.91B$2.70B$2.67B$2.21B$2.34B$1.41B$1.50B$3.18B
Capital Expenditures$760.85M$667.98M$487.17M$458.36M$496.32M$438.22M$369.68M$310.22M$336.41M$466.40M$464.62M
Free Cash Flow$4.06B$3.21B$3.00B$3.45B$2.21B$2.23B$1.84B$2.03B$1.07B$1.04B$2.71B
Share Repurchasesn/a$435.47M$1.49B$1.18B$483.70M$82.15M$420.45M$674.03M$639.24M$329.93M$2.27B
Dividends Paid$468.07M$437.08M$416.17M$398.75M$391.69M$366.65M$343.58M$338.97M$333.04M$320.27M$288.48M
Shares Outstanding190.83M193.94M194.94M200.81M206.20M208.09M204.23M206.76M213.22M217.99M220.05M
Dividends Per Sharen/a$2.20$2.04$1.94$1.84$1.76$1.66$1.60$1.52$1.46$1.36
Weighted Average Diluted Sharesn/a195.21M200.28M204.59M211.21M208.47M204.78M211.84M220.34M221.60M225.96M
EPS (Basic)n/a$8.02$7.60$8.62$8.15$7.48-$16.65$4.07$7.61$1.67$6.73

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView